In a recent SEC filing, Celcuity Inc. submitted a Form D/A, indicating a change or amendment to a previously filed Form D. Form D is a document required to be filed with the Securities and Exchange Commission by companies that have issued securities in a private placement. The details of the amendment made by Celcuity Inc. were not specified in the alert, but such filings are typically made to update information related to the offering.
Celcuity Inc. is a company that focuses on discovering new cancer subtypes and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients. Their innovative approach involves analyzing patient-derived data to identify specific cellular activity that can be targeted for treatment. To learn more about Celcuity Inc., visit their website at https://www.celcuity.com/.
Form D/A filings are commonly made by companies to report changes to a previously submitted Form D. These changes could include updates to the offering amount, the total amount sold, or other details related to the securities being offered. It is important for investors and stakeholders to review these filings to stay informed about any developments or modifications to the company’s private placement activities.
Read More:
Celcuity Inc. Submits D/A SEC Filing (0001603454) as Filer
Leave a Reply